Antiangiogenic therapy for breast cancer

Angiogenesis is an important component of cancer growth, invasion and metastasis. Therefore, inhibition of angiogenesis is an attractive strategy for treatment of cancer. We describe existing clinical trials of antiangiogenic agents and the challenges facing the clinical development and optimal use...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Dorte Lisbet, Andersson, Michael, Andersen, Jon Lykkegaard, Kamby, Claus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096961/
https://www.ncbi.nlm.nih.gov/pubmed/21067536
http://dx.doi.org/10.1186/bcr2642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096961/
https://www.ncbi.nlm.nih.gov/pubmed/21067536
http://dx.doi.org/10.1186/bcr2642

Ejemplares similares